Logo Lanfrica

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice

Type de record:

paper
Créateur:
AndVeeFraJor
Éditeur:
Elsevier BV
Hôte:

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-licensehttp://www.elsevier.com/open-access/userlicense/1.0/

Similaires

Pharmacokinetic-pharmacodynamic assessment of the safety of fexinidazole for the treatment of human African trypanosomiasis

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole

Human African Trypanosomiasis (HAT or sleeping sickness) is a life-threatening neglected tropical di

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis

Long-term sequelae of congenital gambiense human African trypanosomiasis

Abstract Background The clinical presentati

<i>Trypanosoma brucei gambiense</i>-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis

Abstract Background The World Health Organi

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study